Monday, July 4, 2022

Tissue Regenix appoints group finance director

Tissue Regenix Group PLC (LON:TRX) has named Paul Devlin as its group finance director and company secretary.

The regenerative medical devices company said Devlin brings a wealth of experience, having worked on both domestic and international mergers and acquisitions, business transformations, large and small scale business start ups, joint ventures and disposals throughout the last 20 years.

Prior to joining Tissue Regenix he was on an interim assignment for a private equity house. Earlier, Mr Devlin was group finance director at Fletchers Bakeries Limited, which was sold to Finsbury Food Group PLC in October 2014.

“He will play a pivotal role in the strategic direction of Tissue Regenix over the coming years and the experience he brings will be invaluable to the company as we accelerate the breadth, depth and scope of our commercial activity,” said Antony Odell, chief executive of Tissue Regenix.


The articles are for information purposes only and Invest for Property shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.

Invest for Property does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.

There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.

Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.

Leave a Reply